Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel R Meldrum

Showing results (91-100 of 155) with videos related to

Pageof 16
Sort By:
Shock (Augusta, Ga.)|November 23, 2006
Sex dimorphisms in activated mesenchymal stem cell functionPaul R Crisostomo, Meijing Wang, Christine M Herring, et al.
The Journal of Surgical Research|September 21, 2010
Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosisHiroshi Asanuma, Brian A Vanderbrink, Matthew T Campbell, et al.
Shock (Augusta, Ga.)|February 18, 2010
Ablation of TNF-alpha receptors influences mesenchymal stem cell-mediated cardiac protection against ischemiaJiangning Tan, Brent R Weil, Aaron M Abarbanell, et al.
The Journal of Urology|October 28, 2008
Tumor necrosis factor-alpha induces intrinsic apoptotic signaling during renal obstruction through truncated bid activationMatthew T Campbell, Pierre Dagher, Karen L Hile, et al.
The Journal of Surgical Research|November 27, 2007
The right heart and its distinct mechanisms of development, function, and failureTroy A Markel, George M Wairiuko, Tim Lahm, et al.
Shock (Augusta, Ga.)|June 20, 2007
Stem cell mechanisms and paracrine effects: potential in cardiac surgeryPaul R Crisostomo, Meijing Wang, Troy A Markel, et al.
Plos One|December 15, 2010
TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotectionYue Wang, Aaron M Abarbanell, Jeremy L Herrmann, et al.
Shock (Augusta, Ga.)|January 26, 2011
IL-6 and TGF-α costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanismsJeremy L Herrmann, Brent R Weil, Aaron M Abarbanell, et al.
The Journal of Surgical Research|September 28, 2010
The immunomodulatory properties of mesenchymal stem cells: implications for surgical diseaseBrent R Weil, Mariuxi C Manukyan, Jeremy L Herrmann, et al.
Shock (Augusta, Ga.)|September 16, 2008
Angiopoietin-1 in the treatment of ischemia and sepsisNathan M Novotny, Tim Lahm, Troy A Markel, et al.
Pageof 16

Showing results (91-100 of 155) with videos related to

Sort By:
Pageof 16
Shock (Augusta, Ga.)|November 23, 2006
Sex dimorphisms in activated mesenchymal stem cell functionPaul R Crisostomo, Meijing Wang, Christine M Herring, et al.
The Journal of Surgical Research|September 21, 2010
Arterially delivered mesenchymal stem cells prevent obstruction-induced renal fibrosisHiroshi Asanuma, Brian A Vanderbrink, Matthew T Campbell, et al.
Shock (Augusta, Ga.)|February 18, 2010
Ablation of TNF-alpha receptors influences mesenchymal stem cell-mediated cardiac protection against ischemiaJiangning Tan, Brent R Weil, Aaron M Abarbanell, et al.
The Journal of Urology|October 28, 2008
Tumor necrosis factor-alpha induces intrinsic apoptotic signaling during renal obstruction through truncated bid activationMatthew T Campbell, Pierre Dagher, Karen L Hile, et al.
The Journal of Surgical Research|November 27, 2007
The right heart and its distinct mechanisms of development, function, and failureTroy A Markel, George M Wairiuko, Tim Lahm, et al.
Shock (Augusta, Ga.)|June 20, 2007
Stem cell mechanisms and paracrine effects: potential in cardiac surgeryPaul R Crisostomo, Meijing Wang, Troy A Markel, et al.
Plos One|December 15, 2010
TLR4 inhibits mesenchymal stem cell (MSC) STAT3 activation and thereby exerts deleterious effects on MSC-mediated cardioprotectionYue Wang, Aaron M Abarbanell, Jeremy L Herrmann, et al.
Shock (Augusta, Ga.)|January 26, 2011
IL-6 and TGF-α costimulate mesenchymal stem cell vascular endothelial growth factor production by ERK-, JNK-, and PI3K-mediated mechanismsJeremy L Herrmann, Brent R Weil, Aaron M Abarbanell, et al.
The Journal of Surgical Research|September 28, 2010
The immunomodulatory properties of mesenchymal stem cells: implications for surgical diseaseBrent R Weil, Mariuxi C Manukyan, Jeremy L Herrmann, et al.
Shock (Augusta, Ga.)|September 16, 2008
Angiopoietin-1 in the treatment of ischemia and sepsisNathan M Novotny, Tim Lahm, Troy A Markel, et al.
Pageof 16